Genentech Logo
Banner Image
January Monday, Jan 30, 2012
FDA Approves Erivedge (Vismodegib) Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma

Friday, Jan 13, 2012
Genentech Announces First Milestone Payment to Device-Maker ForSight VISION4, Inc. in Development of Sustained Delivery Lucentis

December Wednesday, Dec 07, 2011
Genentech Announces Positive Results of Pivotal Phase III Study with Pertuzumab in HER2-Positive Metastatic Breast Cancer

November Tuesday, Nov 29, 2011
Genentech to Present Important New Data for HER2-Positive Breast Cancer at 2011 San Antonio Breast Cancer Symposium

Friday, Nov 18, 2011
FDA Commissioner Announces Final Decision on Avastin for Metastatic Breast Cancer

Tuesday, Nov 08, 2011
FDA Accepts Genentech's New Drug Application For Vismodegib in Advanced Form of Skin Cancer

Saturday, Nov 05, 2011
Data Showed ACTEMRA Monotherapy Significantly Improved Signs and Symptoms of Rheumatoid Arthritis

See the Archives See the Archives
 
Search Releases

Begin Date:


End Date:


Category:
Keyword: